Loading
FDA approves 9 generic versions of nerve pain drug Lyrica
CNBC
Mon, 22 Jul 2019 20:54

FDA approves 9 generic versions of nerve pain drug Lyrica

CNBC
Mon, 22 Jul 2019 20:54

A bottle of Pfizer Inc.

FDA approves 9 generic versions of nerve pain drug Lyrica
Lyrica medicine sits on a shelf at a pharmacy in Princeton, Illinois, U.S.

Daniel Acker | Bloomberg | Getty Images
The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.

The agency on Monday said it approved nine generic versions of Pfizers Lyrica. It is also used for seizures and fibromyalgia, a condition that causes chronic, widespread pain.
Lyrica, approved in 2004, is Pfizers second bestseller, with sales last year of $4.6 billion. The heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. Prices can vary widely.

Prices for generic versions range from about $140 to $370 per month, according to the drug price comparison site GoodRx.

Common side effects include dizziness, blurred vision and sleepiness. Serious side effects include allergic reactions and life-threatening breathing problems.